On this page
RD3
RD3 regulator of GUCY2D
RD3 is located on the long (q) arm of chromosome 1, at band 1q32.3. Arm ratio per GRCh38 - banding schematic.
Explore chromosome 1 in the library →Available at Jeen Health
Clinical tests that include this
Overview
RD3 encodes a regulatory protein involved in photoreceptor development and function within the retina. The gene's name reflects its role as a regulator of GUCY2D, a guanylate cyclase enzyme that maintains cyclic GMP levels in photoreceptor cells. This regulatory relationship is fundamental to the phototransduction cascade, the process by which light signals are converted into electrical impulses that the brain interprets as vision.
Pathogenic changes in RD3 can disrupt normal photoreceptor biology, leading to inherited retinal conditions. The gene is located on chromosome 1 and produces a relatively small protein of 195 amino acids. Understanding RD3 function is important for elucidating the molecular mechanisms underlying certain forms of inherited vision loss.
What the gene does
The RD3 protein functions primarily as a regulator of retinal guanylate cyclase, specifically GUCY2D. Guanylate cyclases synthesise cyclic GMP, a crucial second messenger in photoreceptor cells that controls ion channel opening and thereby influences photoreceptor membrane potential. RD3 appears to facilitate proper localisation and activity of GUCY2D within photoreceptor outer segments, the specialised cellular compartments where light detection occurs.
By modulating GUCY2D activity, RD3 helps maintain appropriate cyclic GMP concentrations in photoreceptors during both light and dark adaptation. This regulation is essential for the recovery phase of phototransduction, when photoreceptors reset after responding to light stimuli. The protein's regulatory function ensures that photoreceptor cells can respond appropriately to varying light conditions, supporting normal visual perception across a range of illumination levels.
Video: Genetics 101
Chromosome location
RD3 is located on the long arm of chromosome 1 at position 1q32.3. This chromosomal region contains genes involved in various cellular processes, and the specific band designation helps identify the precise genomic coordinates where RD3 resides. The gene's location on chromosome 1 places it among the largest human chromosomes, which harbour numerous genes contributing to diverse biological functions throughout the body.
Protein structure
The RD3 protein comprises 195 amino acids and contains distinct structural features that contribute to its function. A coiled coil domain spans amino acids 23 through 52 near the N-terminus, which typically facilitates protein-protein interactions and may be important for RD3's regulatory role with GUCY2D. The C-terminal region from amino acids 170 to 195 is disordered, meaning it lacks fixed three-dimensional structure under physiological conditions. Disordered regions often confer functional flexibility, allowing proteins to interact with multiple binding partners or undergo conformational changes in response to cellular signals.
Key variants
Genetic variants in RD3 encompass a range of sequence changes, including missense variants that alter single amino acids, nonsense variants that introduce premature stop codons, and small insertions or deletions. The functional impact of individual variants depends on their location within the protein sequence and their effect on protein stability, folding, or interactions with GUCY2D. Variants affecting critical regions such as the coiled coil domain may be particularly disruptive to normal RD3 function.
No pathogenic or likely-pathogenic ClinVar variants recorded yet for this gene.
Associated conditions
Pathogenic variants in RD3 are associated with inherited retinal disorders characterised by photoreceptor dysfunction. These conditions typically follow autosomal recessive inheritance, meaning affected individuals carry pathogenic variants in both copies of the gene. The clinical presentation often involves early-onset vision problems due to impaired photoreceptor development or maintenance. Severity and progression can vary depending on the specific variants involved and their impact on RD3 protein function. Genetic testing through ophthalmology panels can identify RD3 variants in individuals with unexplained retinal disease.
No disease links recorded for this gene in our reference set.
UK clinical status
RD3 is included in the NHS Genomic Medicine Service Retinal disorders panel with green classification (version R32), indicating sufficient evidence for its clinical use in diagnosing inherited retinal conditions. This green rating reflects established gene-disease relationships supported by published evidence. Inclusion in this national panel means RD3 is routinely analysed when patients with suspected inherited retinal disorders undergo genetic testing through the NHS, facilitating accurate molecular diagnosis and enabling appropriate clinical management and family counselling.
Sources: NHS GMS PanelApp · Genomics England PanelApp · NHS National Genomic Test Directory
Frequently asked questions
What does the RD3 gene do?
RD3 produces a protein that regulates GUCY2D, an enzyme essential for maintaining cyclic GMP levels in photoreceptor cells. This regulatory function is critical for normal visual signal processing in the retina.
How are RD3 variants inherited?
RD3-associated retinal conditions typically follow autosomal recessive inheritance, meaning an individual must inherit pathogenic variants from both parents to develop the condition. Carriers with one variant generally do not show symptoms.
Is RD3 tested in NHS genetic panels?
Yes, RD3 is included in the NHS Genomic Medicine Service Retinal disorders panel with green classification, meaning it is routinely analysed during genetic testing for inherited retinal conditions through the NHS.